Anxiety disorders often occur together with other mental illnesses and influence their course, severity and treatability. The present study by Zlomuzica and colleagues addresses the question of how findings from basic research on the generalization of extinction and exposure learning can help to improve treatment strategies for people with comorbid anxiety. Exposure therapy is considered one of the most effective methods for treating anxiety disorders. It is based on the principle that repeated confrontations with anxiety-provoking stimuli in the absence of negative consequences lead to a reduction in anxiety. However, the authors emphasize that this process should not be understood as an erasure of old memory content, but rather as the acquisition of new knowledge that inhibits the original stimulus-fear connection. This new learning is highly context-dependent and can be influenced by situational factors. Clinical reality shows that extinction learning is often not transferred to situations outside the therapeutic context, which increases the risk of relapse. Learning processes can be impaired, particularly in the case of comorbid mental illnesses, which highlights the need for a deeper examination of generalization mechanisms.
Autoren
- Tanja Schliebe
Publikation
- Depression und Angstörungen-Special
Related Topics
You May Also Like
- Plastic surgery and reconstructive microsurgery for DFS
Functional limb preservation between infection control, vascular medicine and resurfacing
- SURPASS-CVOT
Tirzepatide versus Dulaglutide in T2D with ASCVD
- Secondary prevention after ACS: individually optimized lipid management
Trend towards early combination therapy and new strategies for lowering Lp(a)
- Pediatric Brain Tumors
Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls
- What the latest studies on the entire EF spectrum mean for clinical practice
Heart Failure – The 2026 Evidence Update
- Acute ischemic stroke
Alteplase and Tenecteplase Are on the Same Level
- CKD in People with Type 2 Diabetes: Evidence-Based, Optimized Treatment
SGLT-2 inhibitors and GLP-1 receptor agonists: significant improvement in renal outcomes
- Wearables: screening via smartwatch?